Plasma HIV viral rebound following protocol-indicated cessation of ART commenced in primary and chronic HIV infection.
The magnitude of HIV viral rebound following ART cessation has consequences for clinical outcome and onward transmission. We compared plasma viral load (pVL) rebound after stopping ART initiated in primary (PHI) and chronic HIV infection (CHI).Two populations with protocol-indicated ART cessation fr...
| Main Authors: | , , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2012-01-01
|
| Series: | PLoS ONE |
| Online Access: | http://europepmc.org/articles/PMC3432055?pdf=render |
| _version_ | 1818941297821483008 |
|---|---|
| author | Elizabeth Hamlyn Fiona M Ewings Kholoud Porter David A Cooper Giuseppe Tambussi Mauro Schechter Court Pedersen Jason F Okulicz Myra McClure Abdel Babiker Jonathan Weber Sarah Fidler INSIGHT SMART and SPARTAC Investigators |
| author_facet | Elizabeth Hamlyn Fiona M Ewings Kholoud Porter David A Cooper Giuseppe Tambussi Mauro Schechter Court Pedersen Jason F Okulicz Myra McClure Abdel Babiker Jonathan Weber Sarah Fidler INSIGHT SMART and SPARTAC Investigators |
| author_sort | Elizabeth Hamlyn |
| collection | DOAJ |
| description | The magnitude of HIV viral rebound following ART cessation has consequences for clinical outcome and onward transmission. We compared plasma viral load (pVL) rebound after stopping ART initiated in primary (PHI) and chronic HIV infection (CHI).Two populations with protocol-indicated ART cessation from SPARTAC (PHI, n = 182) and SMART (CHI, n = 1450) trials.Time for pVL to reach pre-ART levels after stopping ART was assessed in PHI using survival analysis. Differences in pVL between PHI and CHI populations 4 weeks after stopping ART were examined using linear and logistic regression. Differences in pVL slopes up to 48 weeks were examined using linear mixed models and viral burden was estimated through a time-averaged area-under-pVL curve. CHI participants were categorised by nadir CD4 at ART stop.Of 171 PHI participants, 71 (41.5%) rebounded to pre-ART pVL levels, at a median of 50 (95% CI 48-51) weeks after stopping ART. Four weeks after stopping treatment, although the proportion with pVL ≥ 400 copies/ml was similar (78% PHI versus 79% CHI), levels were 0.45 (95% CI 0.26-0.64) log(10) copies/ml lower for PHI versus CHI, and remained lower up to 48 weeks. Lower CD4 nadir in CHI was associated with higher pVL after ART stop. Rebound for CHI participants with CD4 nadir >500 cells/mm(3) was comparable to that experienced by PHI participants.Stopping ART initiated in PHI and CHI was associated with viral rebound to levels conferring increased transmission risk, although the level of rebound was significantly lower and sustained in PHI compared to CHI. |
| first_indexed | 2024-12-20T06:53:18Z |
| format | Article |
| id | doaj.art-4a73ca6f3638441eb7838abdf15b1e8d |
| institution | Directory Open Access Journal |
| issn | 1932-6203 |
| language | English |
| last_indexed | 2024-12-20T06:53:18Z |
| publishDate | 2012-01-01 |
| publisher | Public Library of Science (PLoS) |
| record_format | Article |
| series | PLoS ONE |
| spelling | doaj.art-4a73ca6f3638441eb7838abdf15b1e8d2022-12-21T19:49:26ZengPublic Library of Science (PLoS)PLoS ONE1932-62032012-01-0178e4375410.1371/journal.pone.0043754Plasma HIV viral rebound following protocol-indicated cessation of ART commenced in primary and chronic HIV infection.Elizabeth HamlynFiona M EwingsKholoud PorterDavid A CooperGiuseppe TambussiMauro SchechterCourt PedersenJason F OkuliczMyra McClureAbdel BabikerJonathan WeberSarah FidlerINSIGHT SMART and SPARTAC InvestigatorsThe magnitude of HIV viral rebound following ART cessation has consequences for clinical outcome and onward transmission. We compared plasma viral load (pVL) rebound after stopping ART initiated in primary (PHI) and chronic HIV infection (CHI).Two populations with protocol-indicated ART cessation from SPARTAC (PHI, n = 182) and SMART (CHI, n = 1450) trials.Time for pVL to reach pre-ART levels after stopping ART was assessed in PHI using survival analysis. Differences in pVL between PHI and CHI populations 4 weeks after stopping ART were examined using linear and logistic regression. Differences in pVL slopes up to 48 weeks were examined using linear mixed models and viral burden was estimated through a time-averaged area-under-pVL curve. CHI participants were categorised by nadir CD4 at ART stop.Of 171 PHI participants, 71 (41.5%) rebounded to pre-ART pVL levels, at a median of 50 (95% CI 48-51) weeks after stopping ART. Four weeks after stopping treatment, although the proportion with pVL ≥ 400 copies/ml was similar (78% PHI versus 79% CHI), levels were 0.45 (95% CI 0.26-0.64) log(10) copies/ml lower for PHI versus CHI, and remained lower up to 48 weeks. Lower CD4 nadir in CHI was associated with higher pVL after ART stop. Rebound for CHI participants with CD4 nadir >500 cells/mm(3) was comparable to that experienced by PHI participants.Stopping ART initiated in PHI and CHI was associated with viral rebound to levels conferring increased transmission risk, although the level of rebound was significantly lower and sustained in PHI compared to CHI.http://europepmc.org/articles/PMC3432055?pdf=render |
| spellingShingle | Elizabeth Hamlyn Fiona M Ewings Kholoud Porter David A Cooper Giuseppe Tambussi Mauro Schechter Court Pedersen Jason F Okulicz Myra McClure Abdel Babiker Jonathan Weber Sarah Fidler INSIGHT SMART and SPARTAC Investigators Plasma HIV viral rebound following protocol-indicated cessation of ART commenced in primary and chronic HIV infection. PLoS ONE |
| title | Plasma HIV viral rebound following protocol-indicated cessation of ART commenced in primary and chronic HIV infection. |
| title_full | Plasma HIV viral rebound following protocol-indicated cessation of ART commenced in primary and chronic HIV infection. |
| title_fullStr | Plasma HIV viral rebound following protocol-indicated cessation of ART commenced in primary and chronic HIV infection. |
| title_full_unstemmed | Plasma HIV viral rebound following protocol-indicated cessation of ART commenced in primary and chronic HIV infection. |
| title_short | Plasma HIV viral rebound following protocol-indicated cessation of ART commenced in primary and chronic HIV infection. |
| title_sort | plasma hiv viral rebound following protocol indicated cessation of art commenced in primary and chronic hiv infection |
| url | http://europepmc.org/articles/PMC3432055?pdf=render |
| work_keys_str_mv | AT elizabethhamlyn plasmahivviralreboundfollowingprotocolindicatedcessationofartcommencedinprimaryandchronichivinfection AT fionamewings plasmahivviralreboundfollowingprotocolindicatedcessationofartcommencedinprimaryandchronichivinfection AT kholoudporter plasmahivviralreboundfollowingprotocolindicatedcessationofartcommencedinprimaryandchronichivinfection AT davidacooper plasmahivviralreboundfollowingprotocolindicatedcessationofartcommencedinprimaryandchronichivinfection AT giuseppetambussi plasmahivviralreboundfollowingprotocolindicatedcessationofartcommencedinprimaryandchronichivinfection AT mauroschechter plasmahivviralreboundfollowingprotocolindicatedcessationofartcommencedinprimaryandchronichivinfection AT courtpedersen plasmahivviralreboundfollowingprotocolindicatedcessationofartcommencedinprimaryandchronichivinfection AT jasonfokulicz plasmahivviralreboundfollowingprotocolindicatedcessationofartcommencedinprimaryandchronichivinfection AT myramcclure plasmahivviralreboundfollowingprotocolindicatedcessationofartcommencedinprimaryandchronichivinfection AT abdelbabiker plasmahivviralreboundfollowingprotocolindicatedcessationofartcommencedinprimaryandchronichivinfection AT jonathanweber plasmahivviralreboundfollowingprotocolindicatedcessationofartcommencedinprimaryandchronichivinfection AT sarahfidler plasmahivviralreboundfollowingprotocolindicatedcessationofartcommencedinprimaryandchronichivinfection AT insightsmartandspartacinvestigators plasmahivviralreboundfollowingprotocolindicatedcessationofartcommencedinprimaryandchronichivinfection |